Indegene Ltd

Indegene Limited announced that the merger of Indegene Healthcare Germany GmbH and Trilogy Writing & Consulting GmbH, both indirect wholly owned subsidiaries of Indegene Limited in Germany, was registered with the Commercial Register of the Local Court (Amtsgericht) of Frankfurt am Main on September 9, 2026, making the merger effective on the same date. Following the merger, Trilogy Writing & Consulting GmbH became Indegene Healthcare Germany GmbH, and the combined entity is projected to have a revenue of Euro 20,100,000 for fiscal year 2026-27, with the company stating the reorganization has no material impact on its business operations, shareholding pattern, or financial position.

Indegene Limited announced that shareholders approved the appointment of Ms. Jill Mary De Simone (DIN:11483134) as an Independent Director at the company's 28th Annual General Meeting held on August 13, 2026, for a term of three years, effective January 22, 2026.

Net profit of Indegene declined 0.17% to Rs 116.20 crore in the quarter ended June 2026 as against Rs 116.40 crore during the previous quarter ended June 2025. Sales rose 39.73% to Rs 1063.10 crore in the quarter ended June 2026 as against Rs 760.80 crore during the previous quarter ended June 2025. ParticularsQuarter EndedJun. 2026Jun. 2025% Var. Sales1063.10760.80 40 OPM %16.3920.41 - PBDT196.80173.70 13 PBT152.70152.10 0 NP116.20116.40 0 Powered by Capital Market - Live

Indegene Limited announced financial results for the quarter ended June 30, 2026, reporting revenue of Rs 10,631 million ($112.5 million), a 39.7% year-over-year increase and a 6.0% sequential increase. The company’s earnings before interest, taxes, depreciation, and amortization were Rs 1,795 million, and profit after tax was Rs 1,162 million, representing margins of 16.9% and 10.9% respectively. Indegene’s active client base increased to 105, with 12 customers now generating more than $10 million in annual revenue each, and revenue per employee strengthened to $77.1 thousand.

Hexaware Technologies Ltd, Allied Blenders & Distillers Ltd, Usha Martin Ltd, Capri Global Capital Ltd are among the other stocks to see a surge in volumes on BSE today, 28 July 2026.Indegene Ltd witnessed volume of 2.39 lakh shares by 10:46 IST on BSE, a 22.66 times surge over two-week average daily volume of 10546 shares. The stock increased 0.64% to Rs.511.40. Volumes stood at 14077 shares in the last session.Hexaware Technologies Ltd witnessed volume of 4.18 lakh shares by 10:46 IST on BSE, a 22.26 times surge over two-week average daily volume of 18763 shares. The stock increased 6.81% to Rs.599.00. Volumes stood at 16613 shares in the last session.Allied Blenders & Distillers Ltd registered volume of 2.67 lakh shares by 10:46 IST on BSE, a 12.22 fold spurt over two-week average daily volume of 21818 shares. The stock slipped 1.38% to Rs.615.95. Volumes stood at 19360 shares in the last session.Usha Martin Ltd registered volume of 1.46 lakh shares by 10:46 IST on BSE, a 8.65 fold spurt over two-week average daily volume of 16851 shares. The stock rose 0.96% to Rs.506.70. Volumes stood at 14179 shares in the last session.Capri Global Capital Ltd saw volume of 6.81 lakh shares by 10:46 IST on BSE, a 8.63 fold spurt over two-week average daily volume of 78890 shares. The stock dropped 0.86% to Rs.242.75. Volumes stood at 65766 shares in the last session.Powered by Capital Market - Live

Indegene announced that the 28th Annual General Meeting(AGM) of the company will be held on 13 August 2026.

Indegene has fixed 31 July 2026 as record date for payment of final dividend of Rs 2.25 per equity share for FY 2026.

Indegene will hold a meeting of the Board of Directors of the Company on 30 July 2026.

Indegene announced that the Board of Directors of the Company at its meeting held on 29 April 2026, inter alia, have recommended the final dividend of Rs 2.25 per equity Share (i.e. 112.5%) , subject to the approval of the shareholders.

Net profit of Indegene declined 32.23% to Rs 79.70 crore in the quarter ended March 2026 as against Rs 117.60 crore during the previous quarter ended March 2025. Sales rose 32.80% to Rs 1003.40 crore in the quarter ended March 2026 as against Rs 755.60 crore during the previous quarter ended March 2025. For the full year,net profit declined 1.38% to Rs 401.10 crore in the year ended March 2026 as against Rs 406.70 crore during the previous year ended March 2025. Sales rose 23.64% to Rs 3510.50 crore in the year ended March 2026 as against Rs 2839.30 crore during the previous year ended March 2025. ParticularsQuarter EndedYear EndedMar. 2026Mar. 2025% Var.Mar. 2026Mar. 2025% Var. Sales1003.40755.60 33 3510.502839.30 24 OPM %16.3019.52 -17.6318.82 - PBDT167.20170.00 -2 671.70619.50 8 PBT125.40149.30 -16 545.30539.30 1 NP79.70117.60 -32 401.10406.70 -1 Powered by Capital Market - Live